Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04897074 · ClinicalTrials.gov registry record · NA

Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

A NA study, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT04897074: Completed NA study, sponsored by Akili Interactive Labs.

NCT04897074 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04897074, a NA study, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD

Primary Outcome

Test of Variables of Attention (TOVA)-Attention Comparison Score (ACS) of sustained and selective attention. Measures at Day 1 and Exit/Post-Treatment Visit Day 28 TOVA ACS is a comparison of a subject's scores based on selected measures that persons with an independent diagnosis of ADHD frequently demonstrated. ACS is calculated using the following formula: ACS = Response Time Z score (Half 1) + d' Z score (Half 2) + Variability Z score (Total) + 1.80 where Response Time is the average time i

Interventions

  • DEVICE AKL-T01

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2021-06-29
Est. Completion 2022-09-01
Phase NA
Akili Interactive Labs

13 total trials

What the finished NCT04897074 record still lists

NCT04897074 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which AKL-T01 is the first listed.

NCT04897074 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04897074 about?

NCT04897074 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)". The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD

What is the current status of trial NCT04897074?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2021-06-29. Estimated completion is 2022-09-01.

What interventions are being tested in trial NCT04897074?

The interventions under investigation include: AKL-T01 (DEVICE).

Who is sponsoring clinical trial NCT04897074?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04897074's enrollment target sits among peer trials

165 626th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04897074, the US trial registry maintained by the National Library of Medicine. NCT04897074 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.